Drugs / Spiriva Handihaler
last change Apr 2020 re-read 3 minutes ago

Spiriva Handihaler

Developed for
chronic obstructive pulmonary disease
Investigated by
Wake Forest University Health Sciences

Trials 1

2018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT03219866 Oct 2017 → Apr 2020 chronic obstructive pulmonary disease Wake Forest University Health Sciences Terminated No outcome recorded Stop: Enrollment

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Spiriva Handihaler ClinicalTrials.gov intervention name — accepted as the source's own label NCT03219866 ↗